A doctor and public health expert explains why the new federal guidelines expanding cervical cancer screening to at-home ...

RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti ...

The FDA approved pembrolizumab (Keytruda) with chemoradiotherapy (CRT) for patients with stage III-IVA cervical cancer based on International Federation of Gynecology and Obstetrics (FIGO) 2014 ...

Among patients with FIGO 2014 Stage III-IVA cervical cancer, treatment with pembrolizumab plus CRT significantly reduced the risk of disease progression or death by 41% compared with placebo plus CRT.

Dynamics of the immune status in patients with cervical cancer receiving complex treatment with dendritic cell vaccine. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This ...

Merck (NYSE:MRK) said the FDA has approved its oncology drug Keytruda in combination with chemoradiotherapy for the treatment of FIGO 2014 Stage III-IVA cervical cancer. The approval is the drug’s ...

Recognizing these global disparities, ASCO recently created tiered treatment guidelines specifically for the management and care of women with invasive cervical cancer, stratified by availability of ...

AJMC ®: During the COVID-19 pandemic, rates of screening and routine cervical cytology screenings (Papanicolaou tests) considerably declined, particularly in rural areas and among certain racial and ...